A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma

BACKGROUND: COVID‐19 convalescent plasma (CCP) ideally contains high titers of (neutralizing) anti‐SARS‐CoV‐2 antibodies. Several scalable immunoassays for CCP selection have been developed. We designed an enzyme‐linked immunosorbent assay (ELISA) that measures neutralizing antibodies (of all isotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wouters, Elise, Verbrugghe, Caro, Devloo, Rosalie, Debruyne, Isabelle, De Clippel, Dorien, Van Heddegem, Leen, Van Asch, Kristin, Van Gaver, Véronique, Vanbrabant, Miek, Muylaert, An, Compernolle, Veerle, Feys, Hendrik B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Donor Infectious Disease Testing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662007/
https://www.ncbi.nlm.nih.gov/pubmed/34498761
http://dx.doi.org/10.1111/trf.16652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662007/
https://www.ncbi.nlm.nih.gov/pubmed/34498761
http://dx.doi.org/10.1111/trf.16652

Ejemplares similares